[1]
Swamy, P.N. and Kumar, V.S. 2021. Prevalence of adverse drug reactions among MDR-TB patients with different anti tubercular regimens. International journal of health sciences. 5, S2 (Dec. 2021), 693–702. DOI:https://doi.org/10.53730/ijhs.v6nS4.11964.